Fortfahren mit
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 10 mg | Warenkorb auf Verfügbarkeit prüfen | € 124,00 | |
| 50 mg | Warenkorb auf Verfügbarkeit prüfen | € 397,00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C12H21N3O5S3
CAS-Nummer:
Molekulargewicht:
383.51
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenQuality Level
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: ≥10 mg/mL
storage temp.
−20°C
SMILES string
CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O
InChI
1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1
InChI key
HCRKCZRJWPKOAR-JTQLQIEISA-N
Gene Information
human ... CA2(760)
General description
Brinzolamide is a small molecular weight compound that has an ability to bind melanin. This drug is used in ocular therapy.[1]
Application
Brinzolamide has been used as a melanin binding compound or drug in melanin binding assays.[1] It has also been used as a carbonic anhydrase inhibitor (CAI).
Biochem/physiol Actions
Brinzolamide is a carbonic anhydrase II inhibitor
Brinzolamide is a carbonic anhydrase II inhibitor used to lower intraocular pressure.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| assay ≥98% (HPLC) | assay - | assay ≥98% (HPLC) | assay - |
| form powder | form - | form powder | form - |
| Quality Level 100 | Quality Level - | Quality Level 100 | Quality Level 300 |
| storage temp. −20°C | storage temp. −20°C | storage temp. 2-8°C | storage temp. - |
| solubility DMSO: ≥10 mg/mL | solubility - | solubility DMSO: 15 mg/mL (clear solution) | solubility - |
| storage condition desiccated | storage condition - | storage condition - | storage condition - |
Still not finding the right product?
Explore all of our products under Brinzolamid
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Risto S Cvetkovic et al.
Drugs & aging, 20(12), 919-947 (2003-10-21)
Brinzolamide is a highly specific carbonic anhydrase (CA) inhibitor which lowers intraocular pressure (IOP) by reducing the rate of aqueous humour formation. Formulated as a 1% ophthalmic suspension (Azopt) and administered twice or three times daily, brinzolamide is indicated for
James F T Li Yim et al.
Current medical research and opinion, 27(8), 1499-1502 (2011-06-10)
To determine the intraocular pressure (IOP) lowering effect of brinzolamide when added to latanoprost. Patients who were simultaneously on brinzolamide and latanoprost were identified from the large prospective database of patients diagnosed with primary open angle glaucoma, normal tension glaucoma
Rajendra S Kadam et al.
Drug metabolism and disposition: the biological fate of chemicals, 39(9), 1529-1537 (2011-06-16)
Ophthalmic carbonic anhydrase inhibitors have been shown to improve retinal and optic nerve blood flow. However, the relative tissue distributions of commercially available carbonic anhydrase inhibitors to the optic nerve are not known. The objective of this study was to
Global Trade Item Number
| SKU | GTIN |
|---|---|
| SML0216-10MG | 04061837077234 |
| SML0216-50MG | 04061832723327 |

